Literature DB >> 14695328

Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study.

Mark W Head1, Diane Ritchie, Nadine Smith, Victoria McLoughlin, William Nailon, Sazia Samad, Stephen Masson, Matthew Bishop, Linda McCardle, James W Ironside.   

Abstract

Human prion diseases are rare fatal neurodegenerative conditions that occur as acquired, familial, or idiopathic disorders. A key event in their pathogenesis is the accumulation of an altered form of the prion protein, termed PrP(Sc), in the central nervous system. A novel acquired human prion disease, variant Creutzfeldt-Jakob disease, is thought to result from oral exposure to the bovine spongiform encephalopathy agent. This disease differs from other human prion diseases in its neurological, neuropathological, and biochemical phenotype. We have used immunohistochemistry and Western blot techniques to analyze the tissue distribution and biochemical properties of PrP(Sc) in peripheral tissues in a unique series of nine cases of variant Creutzfeldt-Jakob disease. We have compared this with the distribution and biochemical forms found in all of the major subtypes of sporadic Creutzfeldt-Jakob disease and in a case of iatrogenic Creutzfeldt-Jakob disease associated with growth hormone therapy. The results show that involvement of the lymphoreticular system is a defining feature of variant Creutzfeldt-Jakob disease, but that the biochemical isoform of PrP(Sc) found is influenced by the cell type in which it accumulates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695328      PMCID: PMC1602214          DOI: 10.1016/S0002-9440(10)63105-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Protease-resistant prion protein in brain and lymphoid organs of sheep within a naturally scrapie-infected flock.

Authors:  J Y Madec; M H Groschup; D Calavas; F Junghans; T Baron
Journal:  Microb Pathog       Date:  2000-06       Impact factor: 3.738

2.  Diagnosis of new variant Creutzfeldt-Jakob disease.

Authors:  R G Will; M Zeidler; G E Stewart; M A Macleod; J W Ironside; S N Cousens; J Mackenzie; K Estibeiro; A J Green; R S Knight
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

Review 3.  Laboratory diagnosis of variant Creutzfeldt-Jakob disease.

Authors:  J W Ironside; M W Head; J E Bell; L McCardle; R G Will
Journal:  Histopathology       Date:  2000-07       Impact factor: 5.087

4.  Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues.

Authors:  M E Bruce; I McConnell; R G Will; J W Ironside
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

5.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

Authors:  J D Wadsworth; S Joiner; A F Hill; T A Campbell; M Desbruslais; P J Luthert; J Collinge
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

6.  Variant Creutzfeldt-Jakob disease in Hong Kong.

Authors:  R Kay; W Y Lau; H K Ng; Y L Chan; D J Lyon; C A van Hasselt
Journal:  Hong Kong Med J       Date:  2001-09       Impact factor: 2.227

7.  Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: atypical molecular phenotype.

Authors:  M W Head; G Tissingh; B M Uitdehaag; F Barkhof; T J Bunn; J W Ironside; W Kamphorst; P Scheltens
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

Review 8.  Iatrogenic Creutzfeldt-Jakob disease at the millennium.

Authors:  P Brown; M Preece; J P Brandel; T Sato; L McShane; I Zerr; A Fletcher; R G Will; M Pocchiari; N R Cashman; J H d'Aignaux; L Cervenáková; J Fradkin; L B Schonberger; S J Collins
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

9.  Genetic influence on the structural variations of the abnormal prion protein.

Authors:  P Parchi; W Zou; W Wang; P Brown; S Capellari; B Ghetti; N Kopp; W J Schulz-Schaeffer; H A Kretzschmar; M W Head; J W Ironside; P Gambetti; S G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

10.  Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype.

Authors:  H S Lee; P Brown; L Cervenáková; R M Garruto; M P Alpers; D C Gajdusek; L G Goldfarb
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

View more
  49 in total

1.  High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease.

Authors:  S Joiner; J M Linehan; S Brandner; J D F Wadsworth; J Collinge
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-Jakob disease.

Authors:  M W Head; A H Peden; H M Yull; D L Ritchie; R E Bonshek; A B Tullo; J W Ironside
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease.

Authors:  C Ishida; S Okino; T Kitamoto; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

4.  PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.

Authors:  Christian Herzog; Julie Rivière; Nathalie Lescoutra-Etchegaray; Aurore Charbonnier; Virginie Leblanc; Nicole Salès; Jean-Philippe Deslys; Corinne Ida Lasmézas
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 5.  Variant Creutzfeldt-Jakob disease: a cause for concern. Review of the evidence for risk of transmission through abdominal lymphoreticular tissue surgery.

Authors:  S B Olsen; A Sheikh; D Peck; A Darzi
Journal:  Surg Endosc       Date:  2005-05-04       Impact factor: 4.584

6.  Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake.

Authors:  Akihiko Urayama; Rodrigo Morales; Michael L Niehoff; William A Banks; Claudio Soto
Journal:  FASEB J       Date:  2011-05-09       Impact factor: 5.191

7.  Prion shedding from olfactory neurons into nasal secretions.

Authors:  Richard A Bessen; Harold Shearin; Scott Martinka; Ryan Boharski; Diana Lowe; Jason M Wilham; Byron Caughey; James A Wiley
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

8.  Neuroinvasion in prion diseases: the roles of ascending neural infection and blood dissemination.

Authors:  Sílvia Sisó; Lorenzo González; Martin Jeffrey
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-23

9.  Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States.

Authors:  Silvio Notari; Francisco J Moleres; Stephen B Hunter; Ermias D Belay; Lawrence B Schonberger; Ignazio Cali; Piero Parchi; Wun-Ju Shieh; Paul Brown; Sherif Zaki; Wen-Quan Zou; Pierluigi Gambetti
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

10.  Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey.

Authors:  Jonathan P Clewley; Carole M Kelly; Nick Andrews; Kelly Vogliqi; Gary Mallinson; Maria Kaisar; David A Hilton; James W Ironside; Philip Edwards; Linda M McCardle; Diane L Ritchie; Reza Dabaghian; Helen E Ambrose; O Noel Gill
Journal:  BMJ       Date:  2009-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.